Tuesday, November 5, 2019

Assessing Gene Therapy to Upregulate Three Longevity-Associated Genes in Mice

Today’s open access research materials report on results obtained in mice using gene therapy to upregulates protein production of several longevity-associated genes. As expected from prior research into these genes and their influence on the operation of metabolism, health is improved in mouse models of age-related disease. As might also be expected based on past results, some combinations are not effective for reasons that remain to be explored: metabolism is complicated, and pulling on levers and turning dials rarely does exactly what was expected. Evolution does not produce optimal organisms, as seen from the perspective of the individual. This is well illustrated in mice, where any number of single gene alterations, even just dialing up or down the amount of protein produced over time, leads

From http://besthealthnews.com/2019/11/assessing-gene-therapy-to-upregulate-three-longevity-associated-genes-in-mice/?utm_source=rss&utm_medium=rss&utm_campaign=assessing-gene-therapy-to-upregulate-three-longevity-associated-genes-in-mice

from
https://healthnews010.wordpress.com/2019/11/06/assessing-gene-therapy-to-upregulate-three-longevity-associated-genes-in-mice/

From https://jamesjohnson10.blogspot.com/2019/11/assessing-gene-therapy-to-upregulate.html



from
https://jamesjohnson10.wordpress.com/2019/11/06/assessing-gene-therapy-to-upregulate-three-longevity-associated-genes-in-mice/

No comments:

Post a Comment